Physician profile
Junghwan Choi
NPI 1255391710
$6,651.29
in general payments reported to CMS, 2019-2025
11 companies · $1,906 in 2025
The $1,906 reported for 2025 was more than what 79% of Urology providers received nationally (typical 2025 total: $631).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $1,815 · 2020: $348 · 2021: $242 · 2022: $1,206 · 2023: $46.15 · 2024: $1,089 · 2025: $1,906.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $1,769 · Travel and Lodging: $1,272.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $1,768.89 |
| Travel and Lodging | $1,272.00 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Teleflex LLC | $3,730.71 | 2020-2025 | Urolift, Barrigel |
| Neotract INC. | $1,503.99 | 2019-2020 | |
| Janssen Biotech, INC. | $557.82 | 2024-2025 | Carvykti, Rybrevant, Erleada |
| Pfizer INC. | $438.71 | 2019-2020 | |
| Medtronic USA, INC. | $136.72 | 2019 | |
| Novo Nordisk INC | $125.00 | 2021 | |
| Agiliti Surgical, INC. | $65.01 | 2024 | Sonablate Hifu |
| Olympus America INC. | $29.12 | 2025 | Itind System |
| Astellas Pharma US INC | $24.87 | 2019-2020 | |
| Abbvie INC. | $22.49 | 2019 | |
| Allergan, INC. | $16.85 | 2020 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Junghwan Choi listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.